Vitamin D modulates molecular pathways relevant to CRC development, including the downregulation of the COX-2 gene and the upregulation of 15-hydroxyprostaglandin dehydrogenase (15-PDGH), leading to a reduction in local prostaglandin levels and hence inhibiting cancer cell survival [14]. This evidence concerns the gene HPGD and colorectal carcinoma.